Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Novel biocompatible and biodegradable amphoteric poly(amidoamine) (
PAA
) hydrogels were designed for applications as scaffolds for tissue engineering. These hydrogels (
PAA
-
AG1
and
PAA
-AG2) were obtained by polyaddition of 2,2-bisacrylamidoacetic acid with 2-methylpiperazine and 4-aminobutyl guanidine, a bioactive molecule with a known ability to induce adhesion to cell membranes. They contain carboxylic functions in their main chain and interchain connections deriving from two different cross-linking agents: for
PAA
-
AG1
, a multifunctional primary amine, that is, 1,10-decanediamine; for
PAA
-AG2, a purposely synthesized
PAA
(
PAA
-NH(2)) containing pendant NH(2). Both
PAA
-
AG1
and
PAA
-AG2 proved noncytotoxic and adhesive to cell membranes, as ascertained by means of cytotoxicity and proliferation tests carried out on fibroblast cell lines. Good apparent mechanical strength was also observed in the case of
PAA
-AG2, cross-linked with the
PAA
-NH(2). Both
PAA
-
AG1
and
PAA
-AG2 underwent degradation tests under controlled conditions simulating the biological environments, that is, Dulbecco medium at pH 7.4 and 37 degrees C. They completely dissolved within 10 and about 40 days, respectively. In both cases, the degradation products were completely noncytotoxic. All the results of this paper point to the conclusion that agmatine-based
PAA
hydrogels are excellent substrates for cell proliferation.
...
PMID:Novel agmatine-containing poly(amidoamine) hydrogels as scaffolds for tissue engineering. 1600 67